Search research articles
Contact Us
Filters
Showing results (471-480 of 491) with videos related to
Page
of 50
Sort By:
The Journal of Experimental Medicine
|
January 8, 2024
Eomes-dependent mitochondrial regulation promotes survival of pathogenic CD4+ T cells during inflammation
Emeline Joulia, Michaël F Michieletto, Arantxa Agesta, et al.
Immunity
|
June 24, 2026
The transcription factor Eomes drives a stemness program in CD4<sup>+</sup> T cells that promotes anti-tumor immunity in response to immunotherapy
Arantxa Agesta, Chloé Ferrand, Anne-Louise Le Dorze, et al.
Brain : a Journal of Neurology
|
March 1, 2011
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility
Nicolas Couturier, Florence Bucciarelli, Ramil N Nurtdinov, et al.
Annals of Clinical and Translational Neurology
|
October 31, 2014
VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis
Nili Avidan, Rozen Le Panse, Hanne F Harbo, et al.
Gut
|
October 14, 2022
Identification of bacterial lipopeptides as key players in IBS
Camille Petitfils, Sarah Maurel, Gaelle Payros, et al.
Nature Communications
|
February 10, 2023
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, et al.
Nature Communications
|
April 29, 2026
The mannose receptor on sinusoidal lining cells mediates two-step bacterial clearance in the human spleen
Neama Alnabati, Francesco Flandi, Tareq Al Saoudi, et al.
Immunity
|
October 14, 2020
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8<sup>+</sup> T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy
Marianne Weulersse, Assia Asrir, Andrea C Pichler, et al.
Med (New York, N.Y.)
|
August 12, 2023
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials
Alberto Hernando-Calvo, Maria Vila-Casadesús, Yacine Bareche, et al.
Science Translational Medicine
|
April 7, 2010
A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis
Maja Jagodic, Celine Colacios, Rita Nohra, et al.
Page
of 50
Search research articles
Search
Showing results (471-480 of 491) with videos related to
Sort By:
Page
of 50
The Journal of Experimental Medicine
|
January 8, 2024
Eomes-dependent mitochondrial regulation promotes survival of pathogenic CD4+ T cells during inflammation
Emeline Joulia, Michaël F Michieletto, Arantxa Agesta, et al.
Immunity
|
June 24, 2026
The transcription factor Eomes drives a stemness program in CD4<sup>+</sup> T cells that promotes anti-tumor immunity in response to immunotherapy
Arantxa Agesta, Chloé Ferrand, Anne-Louise Le Dorze, et al.
Brain : a Journal of Neurology
|
March 1, 2011
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility
Nicolas Couturier, Florence Bucciarelli, Ramil N Nurtdinov, et al.
Annals of Clinical and Translational Neurology
|
October 31, 2014
VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis
Nili Avidan, Rozen Le Panse, Hanne F Harbo, et al.
Gut
|
October 14, 2022
Identification of bacterial lipopeptides as key players in IBS
Camille Petitfils, Sarah Maurel, Gaelle Payros, et al.
Nature Communications
|
February 10, 2023
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, et al.
Nature Communications
|
April 29, 2026
The mannose receptor on sinusoidal lining cells mediates two-step bacterial clearance in the human spleen
Neama Alnabati, Francesco Flandi, Tareq Al Saoudi, et al.
Immunity
|
October 14, 2020
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8<sup>+</sup> T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy
Marianne Weulersse, Assia Asrir, Andrea C Pichler, et al.
Med (New York, N.Y.)
|
August 12, 2023
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials
Alberto Hernando-Calvo, Maria Vila-Casadesús, Yacine Bareche, et al.
Science Translational Medicine
|
April 7, 2010
A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis
Maja Jagodic, Celine Colacios, Rita Nohra, et al.
Page
of 50